Professor Sheila Glennis Haworth Memorial Symposium on Paediatric PH
A PVRI 2022 Digital webinar
Presentations
- Genetics of pulmonary arterial hypertension: What we can learn by studying children with and without congenital heart disease, Wendy Chung
- Therapeutic options in advanced PVD: Potts shunt versus lung transplantation, Mark Grady
- Stem cells and Regenerative Medicine for Neonatal Lung Disease: implications for COPD, Bernard Thebaud
- Assessment of operability in patients with congenital heart disease and PAH: Fallacies and pitfalls, Erika B. Rosenzweig
- The impact of chronic pulmonary hypertension on ventricular function in extremely premature infants, Gabriela de Carvalho Nunes
- Improving guidance for the correctability of congenital cardiovascular shunts with increased pulmonary vascular resistance, Ronald Day
Poll
Start of webinar poll
1. Talk 1: BMPR2 mutations can be found in patients with pulmonary hypertension with our without congenital heart disease
True - 100%
False - 0%
2. Talk 2: Long term outcomes for children undergoing a Potts shunt are comparable to lung transplantation?
Agree - 57%
Disagree - 43%
3. Talk 3: Is there such thing as a “vascular phenotype” in BPD?
Yes - 86%
No - 14%
4. Talk 4: Once you identify as congenital systemic to pulmonary shunt in a patient with pulmonary hypertension, you should immediately close
Yes - 21%
No - 79%
5. Talk 5: Do you think that all extreme premature infants with any degree of bronchopulmonary dysplasia should be screened for pulmonary hypertension at term?
Yes - 93%
No - 7%
6. Talk 6: Acute vasodilator testing with oxygen and inhaled nitric oxide should be used when using a preoperative hemodynamic evaluation to determine the correctability of a cardiovascular shunt.
Agree - 93%
Disagree - 7%
End of webinar poll
1. Talk 1: BMPR2 mutations can be found in patients with pulmonary hypertension with our without congenital heart disease
True - 100%
False - 0%
2. Talk 2: Long term outcomes for children undergoing a Potts shunt are comparable to lung transplantation?
Agree - 43%
Disagree - 57%
3. Talk 3: Is there such thing as a “vascular phenotype” in BPD?
Yes - 86%
No - 14%
4. Talk 4: Once you identify as congenital systemic to pulmonary shunt in a patient with pulmonary hypertension, you should immediately close
Yes - 21%
No - 79%
5. Talk 5: Do you think that all extreme premature infants with any degree of bronchopulmonary dysplasia should be screened for pulmonary hypertension at term?
Yes - 93%
No - 7%
6. Talk 6: Acute vasodilator testing with oxygen and inhaled nitric oxide should be used when using a preoperative hemodynamic evaluation to determine the correctability of a cardiovascular shunt.
Agree - 93%
Disagree - 7%